Hungry Bone Syndrome Definition
Hungry bone syndrome is a postoperative complication characterized by severe, rapid, profound, and prolonged hypocalcemia with normal or elevated PTH levels, accompanied by hypophosphatemia, hypomagnesemia, and low urinary calcium excretion despite high-dose calcium and active vitamin D supplementation. 1
Clinical and Biochemical Characteristics
The syndrome occurs following parathyroidectomy when the sudden withdrawal of elevated parathyroid hormone causes cessation of osteoclastic bone resorption while osteoblastic activity continues unabated, resulting in massive skeletal uptake of calcium, phosphate, and magnesium. 2, 3
Defining Laboratory Features
The biochemical profile that distinguishes hungry bone syndrome from hypoparathyroidism includes: 1
- Severe hypocalcemia (often <1.9 mmol/L or 76 mg/L)
- Normal or elevated PTH concentration (distinguishing it from hypoparathyroidism where PTH is suppressed)
- Hypophosphatemia (contrasts with hyperphosphatemia in hypoparathyroidism)
- Hypomagnesemia
- Low urinary calcium excretion despite aggressive calcium and 1,25(OH)₂ vitamin D supplementation
Clinical Context and Risk Factors
Hungry bone syndrome should be suspected in patients with: 1
- Major skeletal complications preoperatively, particularly brown tumors
- Severe preoperative vitamin D deficiency
- High bone turnover states prior to surgery
Additional risk factors include older age (>60 years), large parathyroid adenomas, markedly elevated preoperative PTH (>1000-2400 pg/mL), elevated alkaline phosphatase (>150-300 U/L), and radiological evidence of hyperparathyroid bone disease. 4, 2, 5
Temporal Course
The syndrome typically manifests with calcium levels reaching their nadir at 48-72 hours postoperatively, and hypocalcemia may persist for months after successful parathyroidectomy, requiring prolonged intensive supplementation. 6, 2, 5
Diagnostic Monitoring
In severe postoperative hypocalcemia, monitoring must include PTH, phosphate, magnesium, and urinary calcium excretion (24-hour or spot) to distinguish hypoparathyroidism from hungry bone syndrome. 1 This distinction is critical because the two conditions require fundamentally different management approaches—hungry bone syndrome demands aggressive calcium and vitamin D replacement, while hypoparathyroidism requires more cautious supplementation.
Incidence
The syndrome occurs in 25-90% of patients with radiological evidence of hyperparathyroid bone disease versus only 0-6% of patients without skeletal involvement, and affects 20-70% of patients undergoing parathyroidectomy for secondary hyperparathyroidism in end-stage renal disease. 2, 5